Nkarta

-$0.13 (-0.52%) Today
$0.00 (0.00%) As of 12:00 PM UTC after-hours

Why Robinhood?

You can buy or sell Nkarta and other stocks, options, and ETFs commission-free!

About NKTX

Nkarta, Inc. Common Stock, also called Nkarta, is a biopharmaceutical company, which engages in the discovery, development, and commercialization of natural killer cell therapies for the treatment of cancer.

CEO
Paul J. Hastings
Employees
95
Headquarters
South San Francisco, California
Founded
2005

NKTX Key Statistics

Market Cap
821.55M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
190.88K
High Today
$25.32
Low Today
$24.24
Open Price
$25.26
Volume
196.30K
52 Week High
$79.16
52 Week Low
$22.46

NKTX Earnings

-$6.08
-$4.05
-$2.03
$0.00
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 12, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure